These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 26997274)
1. NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia. Nichol JN; Galbraith MD; Kleinman CL; Espinosa JM; Miller WH Cell Rep; 2016 Mar; 14(12):2938-49. PubMed ID: 26997274 [TBL] [Abstract][Full Text] [Related]
2. PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation. Kamashev D; Vitoux D; De Thé H J Exp Med; 2004 Apr; 199(8):1163-74. PubMed ID: 15096541 [TBL] [Abstract][Full Text] [Related]
3. Targeting PKC delta-mediated topoisomerase II beta overexpression subverts the differentiation block in a retinoic acid-resistant APL cell line. McNamara S; Nichol JN; Wang H; Miller WH Leukemia; 2010 Apr; 24(4):729-39. PubMed ID: 20200558 [TBL] [Abstract][Full Text] [Related]
4. Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies. Ablain J; Leiva M; Peres L; Fonsart J; Anthony E; de Thé H J Exp Med; 2013 Apr; 210(4):647-53. PubMed ID: 23509325 [TBL] [Abstract][Full Text] [Related]
5. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML. Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078 [TBL] [Abstract][Full Text] [Related]
6. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655 [TBL] [Abstract][Full Text] [Related]
8. Topoisomerase IIbeta negatively modulates retinoic acid receptor alpha function: a novel mechanism of retinoic acid resistance. McNamara S; Wang H; Hanna N; Miller WH Mol Cell Biol; 2008 Mar; 28(6):2066-77. PubMed ID: 18212063 [TBL] [Abstract][Full Text] [Related]
9. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740 [TBL] [Abstract][Full Text] [Related]
10. Promyelocytic leukemia protein in retinoic acid-induced chromatin remodeling of Oct4 gene promoter. Chuang YS; Huang WH; Park SW; Persaud SD; Hung CH; Ho PC; Wei LN Stem Cells; 2011 Apr; 29(4):660-9. PubMed ID: 21360626 [TBL] [Abstract][Full Text] [Related]
11. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. Park DJ; Chumakov AM; Vuong PT; Chih DY; Gombart AF; Miller WH; Koeffler HP J Clin Invest; 1999 May; 103(10):1399-408. PubMed ID: 10330422 [TBL] [Abstract][Full Text] [Related]
12. Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells. Witcher M; Shiu HY; Guo Q; Miller WH Blood; 2004 Nov; 104(10):3335-42. PubMed ID: 15256426 [TBL] [Abstract][Full Text] [Related]
13. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843 [TBL] [Abstract][Full Text] [Related]
15. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3. Testa U; Grignani F; Barberi T; Fagioli M; Masciulli R; Ferrucci PF; Seripa D; Camagna A; Alcalay M; Pelicci PG Cancer Res; 1994 Aug; 54(16):4508-15. PubMed ID: 7519122 [TBL] [Abstract][Full Text] [Related]
16. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Yoshida H; Kitamura K; Tanaka K; Omura S; Miyazaki T; Hachiya T; Ohno R; Naoe T Cancer Res; 1996 Jul; 56(13):2945-8. PubMed ID: 8674046 [TBL] [Abstract][Full Text] [Related]
17. C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells. Duprez E; Wagner K; Koch H; Tenen DG EMBO J; 2003 Nov; 22(21):5806-16. PubMed ID: 14592978 [TBL] [Abstract][Full Text] [Related]
18. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins. Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177 [TBL] [Abstract][Full Text] [Related]
19. PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human hematopoietic cells. Katerndahl CDS; Rogers ORS; Day RB; Xu Z; Helton NM; Ramakrishnan SM; Miller CA; Ley TJ Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2317690121. PubMed ID: 38648485 [TBL] [Abstract][Full Text] [Related]